Simplex Trading, LLC Sigilon Therapeutics, Inc. Transaction History

Simplex Trading, LLC

  • $2.81 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 02, 2023
SELL
$0.29 - $0.69 $6 - $14
-21 Reduced 1.13%
1,831 $0
Q3 2022

Nov 04, 2022
SELL
$0.48 - $0.86 $0 - $0
-1 Reduced 0.05%
1,852 $0
Q1 2022

May 02, 2022
BUY
$1.24 - $3.03 $1,610 - $3,935
1,299 Added 234.48%
1,853 $2,000
Q4 2021

Feb 23, 2022
BUY
$2.58 - $6.13 $1,429 - $3,396
554 New
554 $1,000

About Sigilon Therapeutics, Inc.

SGTX Quotes by TradingView
  • Ticker SGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,399,300
  • Description
  • Sigilon Therapeutics, Inc., a clinical stage biotechnology company, develops functional cures for patients with chronic diseases. Its lead product candidate is SIG-001, which is in Phase I/II clinical trial to prevent bleeding episodes in patients with moderate to severe Hemophilia A. The company is also developing SIG-005 to treat the non-neuro...
More about SGTX
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email